Table 2 ACS characteristics and treatment among those with and without diabetes.
From: The impact of diabetes on one-year health status outcomes following acute coronary syndromes
Variable | Diabetes (n = 326) | No Diabetes (n = 873) | p-value |
|---|---|---|---|
ACS Characteristics | |||
Type of ACS (%) | Â | Â | Â |
   STEMI | 20% | 31% | <0.001 |
   NSTEMI | 28% | 29% | 0.63 |
   UA | 52% | 40% | <0.001 |
3-Vessel Disease | 58% | 45% | 0.003 |
Coronary Angiography | 68% | 82% | <0.001 |
   STEMI | 95% | 96% |  |
   NSTEMI | 84% | 88% |  |
   UA | 65% | 74% |  |
Reperfusion (acute) (%) | Â | Â | Â |
   PCI | 18% | 33% | <0.001 |
   Thrombolytics | 5% | 8% | 0.02 |
Revascularization (%) | Â | Â | Â |
   PCI | 48% | 62% | <0.001 |
   CABG | 3% | 4% |  |
   Medical Management | 49% | 35% |  |
Discharge Treatment | |||
Aspirin (%) | 92% | 95% | 0.09 |
Beta-blocker (%) | 79% | 81% | 0.41 |
ACE-I or ARB (%) | 81% | 74% | 0.008 |
Statins (%) | 75% | 74% | 0.94 |